The Emerging Role of Nanotechnology in Cell and Organ Transplantation.

Transplantation is often the only choice many patients have when suffering from end-stage organ failure. Although the quality of life improves after transplantation, challenges, such as organ shortages, necessary immunosuppression with associated complications, and chronic graft rejection, limit its wide clinical application. Nanotechnology has emerged in the past 2 decades as a field with the potential to satisfy clinical needs in the area of targeted and sustained drug delivery, noninvasive imaging, and tissue engineering. In this article, we provide an overview of popular nanotechnologies and a summary of the current and potential uses of nanotechnology in cell and organ transplantation.

[1]  C. Vogel,et al.  Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience , 2002, Cancer investigation.

[2]  I. Ko,et al.  In vivo MR Imaging of Tissue-engineered Human Mesenchymal Stem Cells Transplanted to Mouse: a Preliminary Study , 2006, Annals of Biomedical Engineering.

[3]  M. Dana,et al.  Graft failure IV. Immunologic mechanisms of corneal transplant rejection , 2008, International Ophthalmology.

[4]  E. Tasciotti,et al.  Proteomic Profiling of a Biomimetic Drug Delivery Platform. , 2014, Current drug targets.

[5]  Anne L. van de Ven,et al.  Cell source determines the immunological impact of biomimetic nanoparticles. , 2016, Biomaterials.

[6]  J. Kovarik,et al.  Minor influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine. , 1994, Transplantation proceedings.

[7]  G. Kwon,et al.  Polymeric micelles for drug delivery. , 2006, Current pharmaceutical design.

[8]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[9]  B. Sitharaman,et al.  Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. , 2005, Journal of the American Chemical Society.

[10]  Mauro Ferrari,et al.  Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[11]  P. Vos,et al.  Cell encapsulation: Promise and progress , 2003, Nature Medicine.

[12]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[13]  Rishi Paliwal,et al.  Nanocarriers in ocular drug delivery: an update review. , 2009, Current pharmaceutical design.

[14]  M. Olson Applications for ROCK kinase inhibition. , 2008, Current opinion in cell biology.

[15]  Panagiotis D. Karampourniotis,et al.  Nanostructured porous silicon films for terahertz optics , 2012, Nanotechnology.

[16]  Mauro Ferrari,et al.  Multistage vector (MSV) therapeutics. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Hak Soo Choi,et al.  Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[18]  Mauro Ferrari,et al.  Enabling individualized therapy through nanotechnology. , 2010, Pharmacological research.

[19]  Mauro Ferrari,et al.  A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery. , 2010, Lab on a chip.

[20]  Mauro Ferrari,et al.  Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast , 2010, Nature nanotechnology.

[21]  M. Kloc,et al.  Rock1 Inhibitor Abrogates Chronic Rejection in Rat Cardiac Model System , 2012 .

[22]  Li Tang,et al.  Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Vivian Charles McAlister,et al.  Liposomal Formulations of Tacrolimus and Rapamycin Increase Graft Survival and Fiber Outgrowth of Dopaminergic Grafts , 2004, Cell transplantation.

[24]  Vítězslav Bryja,et al.  Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord , 2004, Journal of neuroscience research.

[25]  A. S. Moses,et al.  Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.

[26]  W. Ritschel Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral. , 1996, Clinical transplantation.

[27]  M. Ferrari,et al.  Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics. , 2013, Biomaterials.

[28]  M. Kloc,et al.  Chronic allograft rejection: A significant hurdle to transplant success , 2014, Burns & Trauma.

[29]  Björn Lemmer,et al.  Chronobiology, drug-delivery, and chronotherapeutics. , 2007, Advanced drug delivery reviews.

[30]  S. Oliveira,et al.  Nanobody-based cancer therapy of solid tumors. , 2015, Nanomedicine.

[31]  Hermann Brenner,et al.  Kidney Graft Survival in Europe and the United States: Strikingly Different Long-Term Outcomes , 2013, Transplantation.

[32]  A. Gabizon,et al.  Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin , 2012, Drugs.

[33]  Zongxi Li,et al.  Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. , 2010, Small.

[34]  L. Canham,et al.  The role of nanostructured mesoporous silicon in discriminating in vitro calcification for electrospun composite tissue engineering scaffolds. , 2011, Nanoscale.

[35]  M. Ferrari,et al.  Nanopore Technology for Biomedical Applications , 1999 .

[36]  Benjamin Thierry,et al.  Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells , 2009, Advanced materials.

[37]  C. Harms,et al.  Imaging early endothelial inflammation following stroke by core shell silica superparamagnetic glyconanoparticles that target selectin. , 2014, Nano letters.

[38]  R. Muthupillai,et al.  Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. , 2008, Nano letters.

[39]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[40]  P. Couvreur,et al.  Nanotechnology: Intelligent Design to Treat Complex Disease , 2006, Pharmaceutical Research.

[41]  Lesley W Chow,et al.  Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. , 2008, Transplantation.

[42]  S. Al-Swailem,et al.  Graft failure: II. Ocular surface complications , 2008, International Ophthalmology.

[43]  M. Schnitzler Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[44]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[45]  Yi-Xiang J. Wang Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. , 2011, Quantitative imaging in medicine and surgery.

[46]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. , 2003, Cancer research.

[47]  Serge Muyldermans,et al.  Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.

[48]  S. Ludtke,et al.  Superparamagnetic gadonanotubes are high-performance MRI contrast agents. , 2005, Chemical communications.

[49]  M. Ferrari,et al.  The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. , 2014, Biomaterials.

[50]  Mauro Ferrari,et al.  nan'o·tech·nol'o·gy n. , 2006, Nature nanotechnology.

[51]  Shuren Hu,et al.  Porous silicon ring resonator for compact, high sensitivity biosensing applications. , 2015, Optics express.

[52]  R. Weissleder,et al.  Imaging macrophages with nanoparticles. , 2014, Nature materials.

[53]  E. Hoffman,et al.  Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. , 2003, Academic radiology.

[54]  Jongyoon Han,et al.  Molecular sieving using nanofilters: past, present and future. , 2008, Lab on a chip.

[55]  Y. Liu,et al.  Ultrasensitive nanosensors based on upconversion nanoparticles for selective hypoxia imaging in vivo upon near-infrared excitation. , 2014, Journal of the American Chemical Society.

[56]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[57]  Zhuang Liu,et al.  A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. , 2009, Nature nanotechnology.

[58]  Mauro Ferrari,et al.  Nanochannel Technology for Constant Delivery of Chemotherapeutics: Beyond Metronomic Administration , 2011, Pharmaceutical Research.

[59]  Bo Nilsson,et al.  Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study , 2011 .

[60]  T. Mihaljevic,et al.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.

[61]  Mauro Ferrari,et al.  Hierarchical modeling of diffusive transport through nanochannels by coupling molecular dynamics with finite element method , 2011, J. Comput. Phys..

[62]  M Ferrari,et al.  Microfabricated immunoisolating biocapsules. , 1998, Biotechnology and bioengineering.

[63]  Marcel Warntjes,et al.  Gd2O3 nanoparticles in hematopoietic cells for MRI contrast enhancement , 2011, International journal of nanomedicine.

[64]  Mauro Ferrari,et al.  Investigating Islet Immunoisolation Parameters Using Microfabricated Membranes , 1998 .

[65]  Xin Wang,et al.  In vivo MR imaging of magnetically labeled mesenchymal stem cells transplanted into rat liver through hepatic arterial injection. , 2008, Contrast media & molecular imaging.

[66]  A Grattoni,et al.  Confinement effects on monosaccharide transport in nanochannels. , 2010, The journal of physical chemistry. B.

[67]  Mauro Ferrari,et al.  Sustained Zero‐Order Release of Intact Ultra‐Stable Drug‐Loaded Liposomes from an Implantable Nanochannel Delivery System , 2014, Advanced healthcare materials.

[68]  P. de Vos,et al.  Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. , 2002, Trends in molecular medicine.

[69]  K. Tabbara Pharmacologic strategies in the prevention and treatment of corneal transplant rejection , 2008, International Ophthalmology.

[70]  F. Ris,et al.  Clinical Magnetic Resonance Imaging of Pancreatic Islet Grafts After Iron Nanoparticle Labeling , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[71]  S. Majumdar,et al.  Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.

[72]  Silvia Ferrati,et al.  MP43-20 NANOTECHNOLOGY-BASED IMPLANT FOR LONG TERM TESTOSTERONE REPLACEMENT , 2014 .

[73]  R. D. Stulting,et al.  Design and Methods of the Collaborative Corneal Transplantation Studies , 1993 .

[74]  Do Kyung Kim,et al.  Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. , 2006, Journal of the American Chemical Society.

[75]  G. Korbutt,et al.  Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation , 2004, Diabetologia.

[76]  W. Kao,et al.  Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems , 2010, Expert opinion on drug delivery.

[77]  M. Ferrari,et al.  Scaling and crossovers in molecular transport in nano-fluidic systems , 2013 .

[78]  M. Ferrari,et al.  Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs. , 2012, Contrast media & molecular imaging.

[79]  Mauro Ferrari,et al.  Characterization of a nanogland for the autotransplantation of human pancreatic islets. , 2013, Lab on a chip.

[80]  Mauro Ferrari,et al.  Multi-stage delivery nano-particle systems for therapeutic applications. , 2011, Biochimica et biophysica acta.

[81]  M. Ferrari,et al.  Nanodevices in diagnostics. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[82]  J. Lewsey,et al.  Survival after liver transplantation in the United Kingdom and Ireland compared with the United States , 2007, Gut.

[83]  M. Ferrari,et al.  Degradation and biocompatibility of multistage nanovectors in physiological systems. , 2014, Journal of biomedical materials research. Part A.

[84]  R. Robertson Islet transplantation as a treatment for diabetes - a work in progress. , 2004, The New England journal of medicine.

[85]  Jun Lin,et al.  Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery. , 2013, Small.

[86]  B. Kasiske,et al.  US Renal Data System 2013 Annual Data Report. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[87]  Nuria Sanvicens,et al.  Multifunctional nanoparticles--properties and prospects for their use in human medicine. , 2008, Trends in biotechnology.

[88]  Paola Nicolussi,et al.  Functionalized multiwalled carbon nanotubes as ultrasound contrast agents , 2012, Proceedings of the National Academy of Sciences.

[89]  Mauro Ferrari,et al.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications , 2012, Chinese science bulletin = Kexue tongbao.

[90]  Mauro Ferrari,et al.  Gated and near-surface diffusion of charged fullerenes in nanochannels. , 2011, ACS nano.

[91]  S. Dhar,et al.  Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis , 2013, Proceedings of the National Academy of Sciences.

[92]  Efstathios Karathanasis,et al.  Targeted nanotechnology for cancer imaging. , 2014, Advanced drug delivery reviews.

[93]  J. Bulte,et al.  Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[94]  Mauro Ferrari,et al.  Hierarchically Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor Accumulation , 2014, Advanced functional materials.

[95]  K. Sun,et al.  The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. , 2010, Biomaterials.

[96]  Mauro Ferrari,et al.  Silicon-micromachined direct-pore filters for ultrafiltration , 1997, Photonics West - Biomedical Optics.

[97]  Thomas F. George,et al.  Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[98]  V. Chekhonin,et al.  VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[99]  Aifei Wang,et al.  pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. , 2011, Journal of the American Chemical Society.

[100]  Xiaoyuan Chen,et al.  Nanoparticles for cell labeling. , 2011, Nanoscale.

[101]  Silvia Ferrati,et al.  The nanochannel delivery system for constant testosterone replacement therapy. , 2015, The journal of sexual medicine.

[102]  S. Stupp,et al.  Self-Assembly and Mineralization of Peptide-Amphiphile Nanofibers , 2001, Science.

[103]  A. Humar,et al.  American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[104]  G. Kwon,et al.  In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[105]  S. Yalkowsky,et al.  Solubilization of rapamycin. , 2001, International journal of pharmaceutics.

[106]  M. Ferrari,et al.  Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. , 2013, Small.

[107]  Raoul Kopelman,et al.  Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.

[108]  A. Gabizon,et al.  Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. , 1997, Drugs.

[109]  M. Rosen,et al.  Finding Fluorescent Needles in the Cardiac Haystack: Tracking Human Mesenchymal Stem Cells Labeled with Quantum Dots for Quantitative In Vivo Three‐Dimensional Fluorescence Analysis , 2007, Stem cells.

[110]  D. Rhee,et al.  Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. , 2006, Current opinion in ophthalmology.

[111]  M. Ferrari,et al.  A low-voltage electrokinetic nanochannel drug delivery system. , 2011, Lab on a chip.

[112]  Tatsuya Kin,et al.  Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression1 , 2003, Transplantation.

[113]  Patrick V. Almeida,et al.  The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. , 2013, Biomaterials.

[114]  M. Ferrari,et al.  Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. , 2015, Current drug targets.

[115]  Sung Jae Kim,et al.  Amplified electrokinetic response by concentration polarization near nanofluidic channel. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[116]  Mauro Ferrari,et al.  Cellular association and assembly of a multistage delivery system. , 2010, Small.

[117]  Anna Moore,et al.  In vivo imaging of islet transplantation , 2006, Nature Medicine.

[118]  Peng Yang,et al.  Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. , 2014, Biomaterials.

[119]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[120]  T. Webster,et al.  Nanotechnology and nanomaterials: Promises for improved tissue regeneration , 2009 .

[121]  Mauro Ferrari,et al.  Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane. , 2015, Nanoscale.

[122]  David N Firmin,et al.  Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. , 2006, Tissue engineering.

[123]  Jinming Gao,et al.  Theranostic nanomedicine for cancer. , 2008, Nanomedicine.

[124]  R. Bisht,et al.  Chronomodulated drug delivery system: A comprehensive review on the recent advances in a new sub-discipline of ‘chronopharmaceutics’ , 2011 .

[125]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[126]  Xiaoping Hu,et al.  Long‐circulating liposomal contrast agents for magnetic resonance imaging , 2006, Magnetic resonance in medicine.

[128]  Robert Langer,et al.  Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.

[129]  I. K. Yazdi,et al.  Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials. , 2015, Nanomedicine.

[130]  Mauro Ferrari,et al.  Leveraging nanochannels for universal, zero-order drug delivery in vivo. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[131]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[132]  Ralph Weissleder,et al.  A fluorescent nanosensor for apoptotic cells. , 2006, Nano letters.

[133]  Mauro Ferrari,et al.  Nanotechnologies and regenerative medical approaches for space and terrestrial medicine. , 2012, Aviation, space, and environmental medicine.

[134]  Vivian Charles McAlister,et al.  Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity. , 1999, Transplantation proceedings.

[135]  Li-Jiuan Shen,et al.  Nanomedicines in renal transplant rejection – focus on sirolimus , 2007, International journal of nanomedicine.

[136]  MRI of Auto-Transplantation of Bone Marrow-Derived Stem-Progenitor Cells for Potential Repair of Injured Arteries , 2012, PloS one.

[137]  A Grattoni,et al.  Nanochannel systems for personalized therapy and laboratory diagnostics. , 2010, Current pharmaceutical biotechnology.

[138]  M. Kloc,et al.  Downregulation of RhoA and changes in T cell cytoskeleton correlate with the abrogation of allograft rejection. , 2010, Transplant immunology.

[139]  Anna Moore,et al.  Magnetic Nanoparticles for Cancer Diagnosis and Therapy , 2012, Pharmaceutical Research.